You have 9 free searches left this month | for more free features.

18-343

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Disease State of Oral Upadacitinib in Adolescent Participants

Recruiting
  • Atopic Dermatitis
    • Ichinomiya-shi, Aichi, Japan
    • +35 more
    Jul 27, 2022

    Schizophrenia Trial in Japan, Taiwan (Cariprazine, Placebo)

    Recruiting
    • Schizophrenia
    • Akita-shi, Akita, Japan
    • +48 more
    Jan 12, 2023

    HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,

    Recruiting
    • HER2-positive Gastric Cancer
    • Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
    • Cinrebafusp alfa (PRS-343) in combination with tucatinib
    • Santa Barbara, California
    • +3 more
    Jan 14, 2022

    Tourette Syndrome Trial in Nashville (Ecopipam)

    Recruiting
    • Tourette Syndrome
    • Nashville, Tennessee
      Access Clinical Trials, Inc.
    Aug 28, 2023

    HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer Trial in United States (PRS-343 in

    Unknown status
    • HER2-positive Breast Cancer
    • +3 more
    • PRS-343 in Combination with Atezolizumab
    • Los Angeles, California
    • +7 more
    Jan 29, 2021

    Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),

    Active, not recruiting
    • Colorectal Cancer
    • Cholangiocarcinoma
    • Medtronic pump and Codman catheter
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Oct 3, 2022

    Pulmonary Arterial Hypertension

    Recruiting
    • Pulmonary Disease
    • Pulmonary Hypertension
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      Rectal Cancer Trial in Detroit (Standard of care chemo with the change for avoidance of extensive surgery)

      Recruiting
      • Rectal Cancer
      • Standard of care chemotherapy with the change for avoidance of extensive surgery
      • Detroit, Michigan
        Ascension St. John Hospital
      Jan 30, 2023

      Stage IB-IIIA Non-small Cell Lung Carcinoma Trial in Worldwide (AZD9291 80 mg/40 mg, Placebo AZD9291 80 mg/40 mg, Open-label

      Active, not recruiting
      • Stage IB-IIIA Non-small Cell Lung Carcinoma
      • AZD9291 80 mg/40 mg
      • +2 more
      • Los Angeles, California
      • +240 more
      Jan 12, 2023

      Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

      Recruiting
      • Bladder Cancer
      • Hackensack, New Jersey
      • +4 more
      Aug 26, 2022

      Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

      Not yet recruiting
      • Glioblastoma
      • +2 more
      • SonoCloud-9 (SC9)
      • +3 more
      • Chicago, Illinois
      • +7 more
      Jun 5, 2023

      Bladder Cancer Trial in United States (N-803 and BCG, N-803)

      Recruiting
      • Bladder Cancer
      • Anchorage, Alaska
      • +31 more
      Oct 26, 2022

      Neurodevelopmental Disorders Trial in Montréal (NeuroN-QI, SSC alone)

      Not yet recruiting
      • Neurodevelopmental Disorders
      • NeuroN-QI
      • SSC alone
      • Montréal, Quebec, Canada
        CHU Sainte-Justine
      Oct 11, 2023

      Frailty in Critical Care Unit's Patients

      Not yet recruiting
      • CFS
      • Assesment of CFS
      • (no location specified)
      Nov 2, 2023

      Upper Limb Motor Performance UsingInterface With Haptic Feedback

      Not yet recruiting
      • Healthy
      • Functional test with a haptic device
      • Oro Verde, Entre Ríos, Argentina
        Facultad de Ingeniería, Universidad Nacional de Entre Ríos
      Apr 19, 2023

      Hypertension, Pulmonary Trial in Worldwide (Riociguat (Adempas, BAY63-2521))

      Active, not recruiting
      • Hypertension, Pulmonary
      • Riociguat (Adempas, BAY63-2521)
      • Cali, Valle Del Cauca, Colombia
      • +15 more
      Jan 18, 2023

      Plasma Cell Myeloma Trial in United States (Ixazomib Citrate, Lenalidomide, Placebo Administration)

      Recruiting
      • Plasma Cell Myeloma
      • Ixazomib Citrate
      • +4 more
      • Phoenix, Arizona
      • +221 more
      Jan 28, 2023

      Children That Might be at Risk of Having Retinal Hemorrhages

      Not yet recruiting
      • Retinal Hemorrhage, Bilateral
      • +2 more
      • ophthalmoscopy and fundus photography through dilated pupills
      • (no location specified)
      Oct 18, 2022

      HIV Trial in United States (Indinavir sulfate, Lamivudine, Stavudine)

      Completed
      • HIV Infections
      • Indinavir sulfate
      • +3 more
      • Los Angeles, California
      • +44 more
      Oct 28, 2021

      Arthroplasty, Replacement, Knee Trial in New York (Melatonin 5 mg, Placebo (Vitamin C))

      Recruiting
      • Arthroplasty
      • +3 more
      • Melatonin 5 mg
      • Placebo (Vitamin C)
      • New York, New York
        Hospital for Special Surgery
      Aug 25, 2022

      Pelvic Pain Trial in Beaumont (MILTA Device, " control 1 " fake MILTA device)

      Recruiting
      • Pelvic Pain
      • MILTA Device
      • " control 1 " fake MILTA device
      • Beaumont, France
        Clinique la Chataigneraie
      Jul 20, 2022

      Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Olaparib, Pembrolizumab)

      Recruiting
      • Metastatic Pancreatic Adenocarcinoma
      • Stage IV Pancreatic Cancer AJCC v8
      • Anchorage, Alaska
      • +513 more
      Jan 28, 2023

      Healthy Trial in Abbottabad (Left Nostril Breathing, Conventional)

      Not yet recruiting
      • Healthy
      • Left Nostril Breathing
      • Conventional
      • Abbottābād, KPK, Pakistan
        Women Instritute of Rehabilitation Sciences, Jinnah College of N
      May 26, 2023

      After EPL-rupture After Distal Radius Fracture

      Not yet recruiting
      • Distal Radius Fracture
      • primary suture
      • EIP-transfer
      • (no location specified)
      Mar 2, 2022